Based on recent data, AgeX Therapeutics, Inc. (AGE) shows an Average True Range (ATR) of 2.58 and an Enterprise Value of 31.78M. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into AGE's underlying financial health and market activity.
| ATR | 2.58 |
| Enterprise Value | 31.78M |
| Avg Vol (3 Months) | - |
| Avg Vol (10 Days) | - |
AgeX Therapeutics, Inc. (AGE) technical indicators as of February 6, 2026: the SMA 20 is -22.16%, SMA 50 at -20.62%, and SMA 200 at -44.79%. The RSI 14 value is 41.06, suggesting its current momentum. These technical analysis signals help assess AGE's price trends and potential future movements.
| SMA 20 | -22.16% |
| SMA 50 | -20.62% |
| SMA 200 | -44.79% |
| RSI 14 | 41.06 |
AgeX Therapeutics, Inc. (AGE) stock performance overview as of February 6, 2026: The 52-week high is N/A (currently -68.44% below), and the 52-week low is N/A (currently 1.81% above). Over the past year, AGE's performance is -51.56%, compared to the S&P 500's 8.96% change.
| 52-Week High | N/A |
| 52-Week High Chg | -68.44% |
| 52-Week Low | N/A |
| 52-Week Low Chg | +1.81% |
| S&P 500 52-Week Chg | 8.96% |
According to market data, AgeX Therapeutics, Inc. (AGE) stock's recent performance metrics show that over the last month, AGE is -14.82%, with a Year-to-Date (YTD) performance of -18.02%. Over the past year, the stock has seen a -51.56% change. These figures summarize AGE's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | N/A | N/A | N/A | N/A | N/A | N/A |
| Low | N/A | N/A | N/A | N/A | N/A | N/A |
| Performance | -23.61% | -14.82% | -17.81% | -58.47% | -51.56% | -18.02% |
According to current financial data, AGE stock's P/E (TTM) ratio is -4.75, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for AGE, including P/S (239.30), P/B (65.21), and P/FCF (-1.18), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | AGE | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -4.75 | -1.23 | -5.15 | 32.59 |
| P/S (TTM) | 239.3 | 3.71 | 464.72 | 5.98 |
| P/B (TTM) | 65.21 | 0.2 | 8.93 | 5.45 |
| P/FCF (TTM) | -1.18 | -7 | -192.01 | 31.94 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep